Furthermore, the results from the subcutaneous xenograft model showed that knocking out CBX1 significantly inhibited tumor growth (Figure 3I–K) and that tumor tissues in the CBX1‐knockout group had lower expression of Ki67 and PCNA than those in the sgNC group (Figure S3A,B, Supporting Information). This evidence concerns the gene CBX1 and neoplasm.